Company profile for NMD PHARMA

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Walking and breathing are examples of essential human behaviour that is controlled by the nervous system and powered by contractions of skeletal muscles. Neuromuscular disorders refers to a broad range of conditions in which the communication between the central nervous system and skeletal muscle fails, and patients develop debilitating weakness and fatigue. In patients with neuromuscular disorders the loss of muscle fun...
Walking and breathing are examples of essential human behaviour that is controlled by the nervous system and powered by contractions of skeletal muscles. Neuromuscular disorders refers to a broad range of conditions in which the communication between the central nervous system and skeletal muscle fails, and patients develop debilitating weakness and fatigue. In patients with neuromuscular disorders the loss of muscle functionality leads to reduced mobility and lack of independence and, in turn, markedly reduced quality of life. In severely affected patients the muscle weakness can lead to life-threatening respiratory problems.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Denmark
Address
Address
NMD Pharma, Åbogade 15, 8200 Aarhus N, Denmark
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/09/03/3143279/0/en/NMD-Pharma-Expands-Senior-Leadership-Team-with-the-Appointment-of-Ana-de-Vera-as-Chief-Medical-Officer.html

GLOBENEWSWIRE
03 Sep 2025

https://www.globenewswire.com/news-release/2025/05/13/3079942/0/en/NMD-Pharma-to-present-compelling-preclinical-data-highlighting-the-potential-of-ClC-1-ion-channel-inhibition-to-improve-disease-symptoms-and-progression-in-MuSK-myasthenia-gravis-a.html

GLOBENEWSWIRE
13 May 2025

https://www.globenewswire.com/news-release/2025/05/13/3079735/0/en/NMD-Pharma-to-present-compelling-preclinical-data-highlighting-the-potential-of-ClC-1-ion-channel-inhibition-to-improve-disease-symptoms-and-progression-in-MuSK-myasthenia-gravis-a.html

GLOBENEWSWIRE
13 May 2025

https://www.globenewswire.com/news-release/2025/03/25/3048412/0/en/NMD-Pharma-presents-preclinical-data-highlighting-increased-innervation-of-skeletal-muscle-with-ClC-1-ion-channel-inhibition-treatment-in-neuromuscular-disease-model.html

GLOBENEWSWIRE
25 Mar 2025

https://www.globenewswire.com/news-release/2025/01/06/3004440/0/en/NMD-Pharma-Announces-FDA-Orphan-Drug-Designation-Granted-to-NMD670-for-the-Treatment-of-Patients-with-Charcot-Marie-Tooth-Disease.html

GLOBENEWSWIRE
06 Jan 2025

https://www.globenewswire.com/news-release/2024/12/19/2999710/0/en/NMD-Pharma-Announces-Publication-of-Phase-1-Clinical-Trial-Data-Evaluating-NMD670-in-Healthy-Volunteers-in-the-Journal-Clinical-Pharmacology-Therapeutics.html

GLOBENEWSWIRE
19 Dec 2024

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty